HCW Biologics Inc.
HCWB
$6.02
$0.132.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.25% | 34.87% | 13.56% | 74.46% | -104.61% |
| Total Depreciation and Amortization | -30.33% | -38.61% | 431.54% | -1.15% | -46.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -476.29% | 45.70% | 25.69% | -3.09% | -1.84% |
| Change in Net Operating Assets | 97.92% | -395.55% | -170.94% | -93.88% | 197.60% |
| Cash from Operations | 6.59% | -23.95% | 3.13% | 39.81% | -34.91% |
| Capital Expenditure | -- | -- | -205.66% | -299.46% | 114.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -205.66% | -299.46% | 114.34% |
| Total Debt Issued | -- | -- | -86.75% | 45.13% | 11.43% |
| Total Debt Repaid | 4.92% | -4.84% | -4.73% | -1.72% | 2.02% |
| Issuance of Common Stock | 311,500.00% | -99.98% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3,499.10% | 96.50% | -- | -- | -- |
| Cash from Financing | 8,788.70% | -100.80% | 136.56% | 45.79% | -54.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.32% | -197.02% | 2,354.08% | 94.42% | -697.71% |